Skinvive represents the latest advancement in the realm of facial fillers, combining medical precision with the latest research. Designed for patients aspiring for a youthful appearance without resorting to invasive procedures, Skinvive offers a choice for superficial placement of fillers diretcly into the dermis to improve hydration, texture and skin quality.
Unlike traditional fillers that predominantly target more prominent facial features and deeper wrinkles with cohesive gel formulations, Skinvive adopts a unique method. Its distinctive liquid consistency facilitates micro-droplet injections, adeptly tackling fine lines, skin texture irregularities, volume deficits, and slight skin laxity, particularly around the cheek area. This results in an enhanced skin quality that aligns with the “smooth skin” aesthetic preference Dr. Rokhsar is able to achieve in his patients who desire that look.
With Skinvive, the outcome is consistently natural. The risks of an unnatural or exaggerated appearance, frequently linked with conventional fillers or novice practitioners, are substantially reduced. Consequently, Skinvive establishes itself as a viable alternative to other procedures like laser skin resurfacing, chemical peels, and microneedling.
Skinvive is proven safe and adaptable for all Fitzpatrick skin types (I-VI), ensuring its suitability for a variety of skin shades. After undergoing the treatment, patients can expect a rejuvenated appearance lasting between 6 to 9 months. Composed of a Hyaluronic acid (HA) derivative, Skinvive operates by retaining moisture, resulting in a fuller and more refined skin texture, akin to the renowned Juvéderm dermal fillers. Additionally, the treatment incorporates lidocaine, which minimizes discomfort, and any common side effects, such as swelling, redness, or bruising, typically dissipate within a week.
As you contemplate Skinvive injections or any aesthetic intervention in New York, it’s crucial to select a provider with proven expertise and credentials, something Dr. Rokhsar takes extreme pride in. While nurses and physician assistants might offer injectable treatments, the prescription of fillers should be exclusively from a board certified dermatologist. Ensure the authenticity of the products by acquiring them solely from a licensed board certified dermatologist. Dr. Rokhsar is double board certified in dermatology and dermatologic surgery.
Skinvive is the newest FDA approved filler which has been available in the United States in 2023. It is a less concentrated hyaluronic preparation which allows doctors to inject the material more superficially in the skin in the upper layer of the dermis. This has been shown to result in improvement in the actual texture of the skin. The common areas of Skinvive placement are the cheeks but other areas which can be treated include lines and wrinkles in the upper lip and chin, as well as forehead and neck lines.
The results with Skinvive will last 6 months to 1 year depending on the amount of material injected. Another variable which determines the longevity of injections is the patient’s baseline metabolism. This has been proven with many other fillers as well, as people with higher metabolism such as athletes or runners may break down the filler faster than the average individual.
The results of Skinvive are apparent immediately, however, the skin may be swollen for 1-2 days. Therefore, it’s best to not judge your results until 3-7 days after the injection.
Skinvive can be the treatment of choice for improving skin texture or fine lines in the cheeks. Since it is less concentrated compared to other fillers, it can also be an optimal choice for upper lip, chin, neck, forehead lines and wrinkles.
Allergan makes Skinvive. They are a leader in development in filler and neurotoxins and they’re also the makers of Botox, Juvederm, and Voluma.
Skinvive was FDA approved in the United States in 2023.
Upper East Side Manhattan Office
121 East 60th Street, Suite 8AB New York, NY 10022
Long Island Office
901 Stewart Ave, Suite 240, Garden City, NY 11530